Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
Silymarin
61
CHF
CHF 61.00
In stock
CDX-S0289-G02525 gCHF 61.00
CDX-S0289-G05050 gCHF 108.00
CDX-S0289-G100100 gCHF 170.00
| Product Details | |
|---|---|
| Synonyms | Mixture of flavanonolderivates Silibinin, Isosilibinin, Silicristin and Silidianin. |
| Product Type | Chemical |
| Properties | |
| Formula |
n/a |
| MW | n/a |
| CAS | 65666-07-1 |
| Source/Host Chemicals | Plant |
| Purity Chemicals | ≥30% (HPLC Silybin) |
| Appearance | Yellow to brown powder. |
| Solubility | Soluble in DMSO or ethanol (1mg/ml). |
| Identity | Determined by 1H-NMR. |
| Declaration | Manufactured by Chemodex. |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | -20°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light and moisture. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
Silymarin is a polyphenolic flavonoid extracted from the seeds of Silybum marianum or milk thistle. Silymarin is an isomeric mixture of the flavonolignans silydianin, silychristin, silibinin [Silybin] and isosilybin. It has similar biological properties to its main component Silibinin, including potent antioxidant, anti-inflammatory, anticancer, antidiabetic, hepatoprotective, neuroprotective, cardioprotective, antiviral, antimicrobial and immunosuppressive activities.
Product References
(1) N. Skottova & V. Krecman; Physiol. Res. 47, 1 (1998) (Review) | (2) R.P. Singh & R. Agarwal; Antioxid. Redox Signal. 4, 655 (2002) (Review) | (3) S.K. Katiyar; Int. J. Oncol. 26, 169 (2005) (Review) | (4) K.E. Mayer, et al.; J. Viral. Hepat. 12, 559 (2005) (Review) | (5) R. Agarwal, et al.; Anticancer Res. 26, 4457 (2006) (Review) | (6) K. Ramasamy & R. Agarwal; Cancer Lett. 269, 352 (2008) (Review) | (7) M. Rafieian-Kopaie & H. Nasri; J. Renal Inj. Prev. 1, 3 (2012) (Review) | (8) S.J. Polyak, et al.; Hepatology 57, 1262 (2013) (Review) | (9) A. Borah, et al.; CNS Neurosci. Ther. 19, 847 (2013) (Review) | (10) P.F. Surai; Antioxidants 4, 204 (2015) (Review) | (11) L. Voroneanu, et al.; J. Diabetes Res. 2016, 5147468 (2016) (Review) | (12) K.P. Devi, et al.; Curr. Drug Targets 18, 1529 (2017) (Review) | (13) N. Esmaeil, et al.; Int. Immunopharmacol. 50, 194 (2017) (Review) | (14) M. Vahabzadeh, et al.; J. Sci. Food Agric. 98, 4816 (2018) (Review) | (15) T. Hosseinabadi, et al.; Phytother. Res. 33, 2849 (2019) (Review)